$0.010.01 0.000.00 |(0.000.00 %)
52W H: 5.658852W L: 0.007Beta: 0.25
About CERo Therapeutics Holdings Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.phoenixbiotechacquisitioncorp.com/
Frequently Asked Questions
What is the 52-week range for CERO?
The 52-week high is $5.6588 and the 52-week low is $0.007.
What is the P/E ratio for CERO?
The P/E ratio data is currently unavailable.
What is the dividend yield for CERO?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -4.78%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-03-04 | Francois Eric | +1,823,278 | - | - |
| 2026-01-07 | Pierce Kristen | +1,612,099 | - | - |
| 2026-01-07 | KUCHARCHUK ANDREW ALBERT | +1,162,099 | - | - |
| 2026-01-07 | Rolfe Lindsey | +690,900 | - | - |
| 2026-01-07 | Byrnes Michael | +690,900 | - | - |
| 2026-01-07 | Patel Shami | +690,900 | - | - |
| 2026-01-07 | Ehrlich Christopher B | +4,530,997 | - | - |
| 2026-01-07 | ATWOOD BRIAN G | +1,612,099 | - | - |
| 2026-01-07 | LAPORTE KATHLEEN | +690,900 | - | - |